Founded in the U.S. in 1977, has a track record of creating nearly 100 unicorns and is one of the largest global management firms. Provides consistent support from early stage to growth stage in the technology and healthcare areas.
Founded in the U.S. in 1977, has a track record of creating nearly 100 unicorns and is one of the largest global management firms. Provides consistent support from early stage to growth stage in the technology and healthcare areas.
Purpose is to create 1 trillion yen companies, including unicorns, through vertically integrated support from the pre-seed/seed stage, including sourcing through a unique acceleration program.
Seeking to create unicorns, positions fintech, healthcare, and smart infrastructure as priority investment areas while also investing in deep tech. Promotes open innovation between investee startups and domestic companies.
Makes follow-on investments in promising startups within its portfolio to encourage further growth prior to initial listing. Aims to create unicorns, mainly in the SaaS domain, while providing support for overseas expansion.
With offices in Japan and the U.S., plans to create new businesses in the deep tech field for Society 5.0, including social implementation of deep tech through the introduction of the SaaS model. Supports Japanese startups seeking to expand overseas by leveraging its knowledge of the U.S. market.
EEI Fund 5 Innovation & Impact Investment Limited Partnership
Date announced
September 16, 2022
Amount investedAmount of commitment
JPY6.2 billion (Date of change: December 26, 2023)
Fund summary
As a fund specializing in environment and energy, invests in startups with innovative business models and technologies, contributing to the realization of a sustainable society with a focus on decarbonization in the three investment areas of Energy Transition, Mobility & Transportation, and Smart Society.
Promotes social implementation of technology seeds owned by universities and other institutions through support for deep-tech startups from academia. Promotes global R&D and business development of portfolio startups through collaboration with overseas universities, research institutions, and VCs.
Provides risk capital for deep tech and areas where digital technology promotes the convergence of cyber and physical spaces. Provides human resource support for pre-seed/seed stage R&D startups, and promotes diversity in the ecosystem by fostering female capitalists and entrepreneurs.
Out-licenses promising compounds from domestic pharmaceutical companies and promotes their development on a global scale. Contributes to cultivating a drug discovery startup ecosystem through knowledge sharing and human resource development related to the creation of open innovation through collaboration with drug discovery startups.
Society
Unicorn
Regional technologies
Business consolidation